Skip to content

Released Aug 8, 2022, before the open

10-Q filed Aug 8, 2022, 39 days after period end · 0001493152-22-021567

Q2 2022 · 10-Q
Revenue$500.00Kno prior Q2 2021 on fileno prior Q1 2022 on file
Net Income-$2.63MN/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.61N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$3,527,531N/M
Operating Cash Flowderived-$3,046,329N/M
Free Cash Flowderived-$3,056,631—
Margins · derived
Operating margin-705.5%
Net margin-526.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue$500.00K——$0.00
Net Income-$2.63M-$6.81M-$6.37M-$3.43M
EPS Diluted-$0.61-$0.08-$0.13-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR